Twelve‐month follow‐up results from the SIRONA 2 clinical trial
Abstract Aims In the SIRONA 2 trial, the safety and efficacy of pulmonary artery (PA) pressure (PAP)‐guided heart failure (HF) management using a novel PAP sensor were assessed at 30 and 90 days, respectively, and both endpoints were met. The current study examines the prespecified secondary endpoin...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2024-04-01
|
| Серии: | ESC Heart Failure |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1002/ehf2.14657 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|